Is AstraZeneca PLC halal to invest in?

As of July 2026, AstraZeneca PLC AZN.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is AstraZeneca PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AstraZeneca PLC using these criteria to determine its compliance status.

Can Muslims buy shares of AstraZeneca PLC?

Muslim investors may consider investing in AstraZeneca PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is AstraZeneca PLC classified as HALAL?

Musaffa determines the Shariah status of AstraZeneca PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for AstraZeneca PLC updated?

The Shariah compliance status of AstraZeneca PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like AstraZeneca PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of AstraZeneca PLC?

You can check the latest Shariah compliance status of AstraZeneca PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AstraZeneca PLC AZN.L

Last Updated: Jul 20, 12:00 AM·LSE

AZN.L Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, AstraZeneca PLC is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

AstraZeneca PLC. Stock Analysis AZN.L

United Kingdom Health Care Mega Cap Report: Q1, 2026

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. The firm focuses on the discovery, development, and commercialization of prescription medicines. The firm operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. The company has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The firm distributes its products in over 125 countries.

Key Statistics of AstraZeneca PLC (AZN.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX12,380.00GBX12,634.00

Today's Open

GBX12,504.85

Volume

1.08M

P/E Ratio (TTM)

25.63

52 Week Range

GBX10,198.00GBX15,730.00

Market Cap

22.28T

Avg. Volume

1.42M

Dividend Yield

1.87%

Financial Metrics & Statements of AstraZeneca PLC (AZN.L)

Super Investors Invested in AstraZeneca PLC (AZN.L)

FAQ's for AstraZeneca PLC (AZN.L)

As of July 2026, AstraZeneca PLC AZN.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AstraZeneca PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in AstraZeneca PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of AstraZeneca PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of AstraZeneca PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of AstraZeneca PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.